Project Grant HT94252411050
Award Date
9/15/24
Completion Date
9/14/28
Dollars Obligated
$4.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The University of Texas MD Anderson Cancer Center received a $648,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop CAR T-cell therapy targeting CD94 in T/NK cell malignancies. The award period runs from September 1, 2023 to August 31, 2025. MD Anderson is a comprehensive cancer treatment and research center that has extensive experience conducting federally funded biomedical research, including...
The University of Texas MD Anderson Cancer Center will receive $729,000 through a Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 2021 through August 2025 to translate novel discoveries in gastric adenocarcinoma biology into therapeutic advances. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
The University of Texas MD Anderson Cancer Center will receive $966,730 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 2021 through August 2025 to translate novel discoveries in gastric adenocarcinoma biology into therapeutic advances. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research that...
The University of Texas MD Anderson Cancer Center was awarded a $1,214,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify collateral lethal targets in prostate cancer from September 1, 2021 through August 31, 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...
The University of Texas MD Anderson Cancer Center will receive $728,998 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will support research to translate novel discoveries in gastric adenocarcinoma biology into therapeutic advances from August 2021 through August 2025. The Military Medical Research and Development program aims to transform military and public health through innovative...
The University of Texas MD Anderson Cancer Center received a $567,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, will fund research targeting myeloid mimicry in renal medullary carcinoma, with a completion date of August 31, 2027. Through this federal grant, MD Anderson Cancer Center will conduct innovative scientific studies, ranging from basic laboratory research to advanced...
The Department of the Army Medical Command awarded a $249,999 Project Grant to The University of Texas M.D. Anderson Cancer Center through the Military Medical Research and Development program. This three-year grant will fund research from September 2022 to August 2025 to revisit antiangiogenic therapy and target prostate cancer metabolism. The Military Medical Research and Development program, designated by CFDA #12.420, supports basic, applied, and advanced biomedical research with the goals...
The University of Texas MD Anderson Cancer Center received a $1,007,007.84 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to investigate the complex immunological niche of bone metastasis and its role in therapy response and resistance. Through basic, applied, and advanced biomedical research efforts, the project...
The University of Texas MD Anderson Cancer Center was awarded a $1,295,977 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a measurement burst study from September 2021 through September 2025 to examine short- and long-term change and variability in adjustment trajectories among young adult cancer patient-caregiver dyads. Through the support of basic, applied, and advanced...
The University of Texas MD Anderson Cancer Center will receive $2,172,614 under a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 to September 2025 to develop an integrated genomic and therapeutic strategy for androgen-indifferent prostate cancers. The Military Medical Research and Development program supports biomedical research with the goals of improving...